HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kosuke Kaji Selected Research

SE5-OH

11/2021Association between Equol Production Status and Nonalcoholic Steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kosuke Kaji Research Topics

Disease

47Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 10/2006
35Fibrosis (Cirrhosis)
10/2022 - 11/2006
23Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2007
18Neoplasms (Cancer)
01/2021 - 01/2007
14Fatty Liver
10/2022 - 10/2006
10Alcoholic Fatty Liver
10/2022 - 07/2008
9Non-alcoholic Fatty Liver Disease
11/2021 - 10/2006
8Insulin Resistance
08/2020 - 01/2009
6Infections
03/2022 - 01/2017
6Hepatic Encephalopathy
12/2021 - 12/2017
6Liver Diseases (Liver Disease)
10/2021 - 01/2009
5Hyperammonemia
08/2022 - 12/2017
5Ascites
05/2022 - 08/2017
5Inflammation (Inflammations)
12/2021 - 05/2012
4Sarcopenia
08/2022 - 01/2020
3Thrombophilia
03/2022 - 05/2019
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
03/2022 - 01/2017
3Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2021 - 01/2021
3Cognitive Dysfunction
06/2021 - 03/2020
3Dysbiosis
06/2021 - 01/2018
3Muscle Cramp (Cramp)
12/2020 - 01/2019
3Cholangiocarcinoma
10/2020 - 08/2013
3Carcinogenesis
03/2020 - 10/2006
2Atrophy
08/2022 - 12/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 08/2009
2Acute-On-Chronic Liver Failure
04/2022 - 05/2020
2Pleural Effusion (Pleural Effusions)
03/2022 - 08/2017
2Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
09/2021 - 07/2021
2Liver Neoplasms (Liver Cancer)
01/2021 - 01/2018
2Body Weight (Weight, Body)
01/2021 - 08/2017
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 01/2019
2Thrombocytopenia (Thrombopenia)
09/2020 - 01/2020
2Thrombosis (Thrombus)
09/2020 - 08/2017
2Chronic Hepatitis B
08/2020 - 09/2017

Drug/Important Bio-Agent (IBA)

13Amino AcidsFDA Link
10/2022 - 11/2007
11Choline (Choline Chloride)IBA
10/2022 - 11/2007
11EndotoxinsIBA
05/2022 - 03/2015
10CDAA (Randox)IBA
10/2022 - 11/2007
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 10/2006
9Biomarkers (Surrogate Marker)IBA
04/2022 - 09/2017
9Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2012 - 11/2006
8Losartan (Cozaar)FDA LinkGeneric
01/2022 - 05/2009
7LipopolysaccharidesIBA
10/2022 - 03/2019
7CytokinesIBA
08/2022 - 05/2009
7von Willebrand FactorIBA
04/2022 - 02/2018
7Angiotensin II Type 1 Receptor BlockersIBA
01/2022 - 05/2009
7Angiotensin IIIBA
12/2021 - 10/2006
7InterferonsIBA
09/2018 - 11/2006
6Rifaximin (L 105)FDA Link
10/2022 - 12/2017
6EnzymesIBA
04/2022 - 05/2012
6Branched-Chain Amino AcidsIBA
12/2021 - 01/2009
6CollagenIBA
10/2020 - 12/2008
6Glutathione Transferase (Glutathione S-Transferase)IBA
06/2018 - 10/2006
5Toll-Like Receptor 4IBA
10/2022 - 06/2019
5Proteins (Proteins, Gene)FDA Link
03/2022 - 11/2007
5Carbon Tetrachloride (Tetrachloromethane)IBA
12/2021 - 05/2015
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 09/2017
5Glucose (Dextrose)FDA LinkGeneric
03/2020 - 11/2017
5Pharmaceutical PreparationsIBA
03/2014 - 02/2007
4Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 03/2015
4Angiotensin Receptor AntagonistsIBA
12/2021 - 07/2011
4Carrier Proteins (Binding Protein)IBA
10/2021 - 09/2017
4DiureticsIBA
01/2021 - 08/2017
4AldosteroneIBA
08/2017 - 05/2010
4Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2010 - 10/2006
3TolvaptanFDA Link
05/2022 - 08/2017
3AntigensIBA
04/2022 - 12/2020
3ZincIBA
03/2022 - 06/2021
3Hyaluronic Acid (Hyaluronan)IBA
10/2021 - 08/2020
3Tissue Inhibitor of MetalloproteinasesIBA
10/2021 - 08/2020
3AntioxidantsIBA
06/2021 - 12/2020
3Therapeutic UsesIBA
12/2020 - 01/2008
3Alanine Transaminase (SGPT)IBA
04/2020 - 11/2006
3Sorafenib (BAY 43-9006)FDA Link
12/2019 - 05/2012
3Transforming Growth Factors (Transforming Growth Factor)IBA
03/2019 - 01/2012
3Vitamin KFDA Link
05/2011 - 01/2007
2MyostatinIBA
08/2022 - 03/2022
2SteroidsIBA
03/2022 - 05/2012
2AmmoniaIBA
03/2022 - 03/2020
2Ethanol (Ethyl Alcohol)IBA
12/2021 - 01/2021
2AlbuminsIBA
10/2021 - 09/2019
2BilirubinIBA
10/2021 - 05/2012
2Collagen Type III (Type III Collagen)IBA
10/2021 - 08/2020
2Triglycerides (Triacylglycerol)IBA
09/2021 - 06/2020
2ChemokinesIBA
06/2021 - 11/2016
2Messenger RNA (mRNA)IBA
01/2021 - 11/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 07/2008
2lenvatinibIBA
01/2021 - 01/2021
2Carnitine (L-Carnitine)FDA LinkGeneric
12/2020 - 01/2019
2procollagen Type III-N-terminal peptide (PIIP)IBA
10/2020 - 08/2020
2GemcitabineFDA Link
10/2020 - 08/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2020 - 11/2016
2lusutrombopagIBA
09/2020 - 01/2020
2Antiviral Agents (Antivirals)IBA
08/2020 - 01/2019
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
07/2020 - 01/2017

Therapy/Procedure

21Therapeutics
05/2022 - 11/2006
6Oral Administration
10/2022 - 01/2018
6Drug Therapy (Chemotherapy)
12/2020 - 08/2018
3Liver Transplantation
06/2021 - 03/2011
3Intraperitoneal Injections
01/2021 - 01/2019